DELFI Diagnostics Unveils Blood Test for Enhanced Lung Cancer Screening
DELFI’s blood test provides results by determining the likelihood of detecting lung cancer through low-dose CT, with an NPV of 99.7 percent.
Read More
Search Results for: lung cancer
Blood Tests Identify NSCLC Patients Who May Benefit from Immunotherapies
Liquid biopsies may identify NSCLC patients undergoing immunotherapy who could benefit from treatment with additional drugs.
Read More
Hackensack Meridian Health Research Institute Establishes Cancer Diagnostics Company
EValuate Diagnostics aims to make tests that detect cancer early, and will market a system for the capture of extracellular vesicles.
Read More
Liquid Biopsy May Identify NSCLC Patients Who Will Benefit from Radiation
A novel liquid biopsy test may determine which patients with NSCLC that has spread beyond the lungs will benefit from high-dose radiation.
Read More
Point32Health and GRAIL Expand Pilot Access to Multi-Cancer Early Detection Test
Point32Health and GRAIL announced the expansion of their pilot to offer GRAIL’s Galleri multi-cancer early detection screening test.
Read More